Search
for
Sort by
Research 871–900 of 1000+
- What is the Rationale for Androgen Therapy for Women?
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome
- Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Alopecia Areata of the Beard: A Review of the Literature
- Effects of polycystic ovary syndrome on health-related quality of life
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Twist1 Contributes to the Maintenance of Some Biological Properties of Dermal Papilla Cells in vitro by Forming a Complex With Tcf4 and β-Catenin
- Hair camouflage: A comprehensive review
- The Biology of Hair Growth
- Therapeutic potential of endogenous stem cells and cellular factors for scar-free skin regeneration
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- Polycystic ovary syndrome: a dermatologic approach
- Symptom management in inflammatory bowel disease
- Functional ectodermal organ regeneration as the next generation of organ replacement therapy
- Proprietary Herbal Extract Downregulates the Gene Expression of Il-1 and #945; in HaCaT Cells: Possible Implications Against Nonscarring Alopecia
- Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women
- Endocrine evaluation of hirsutism
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting Partnership
- Polycystic ovary syndrome: diagnosis and management of related infertility
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Localized Telogen Effluvium after Face Lift Surgery
- A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
- Headgear-induced temporary pressure alopecia
- Adalimumab improves health-related quality of life (HRQoL) in patients with moderate to severe hidradenitis suppurativa (HS): Results from the first 12 weeks of PIONEER II
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Diffuse hair loss in women